124 related articles for article (PubMed ID: 37989415)
1. Hydroquinone-selected chronic myelogenous leukemia cells are sensitive to chloroquine-induced cytotoxicity via MCL1 suppression and glycolysis inhibition.
Chiou JT; Lee YC; Chang LS
Biochem Pharmacol; 2023 Dec; 218():115934. PubMed ID: 37989415
[TBL] [Abstract][Full Text] [Related]
2. Hydroquinone destabilizes BIM mRNA through upregulation of p62 in chronic myeloid leukemia cells.
Lee YC; Chiou JT; Wang LJ; Chang LS
Biochem Pharmacol; 2022 May; 199():115017. PubMed ID: 35346662
[TBL] [Abstract][Full Text] [Related]
3. CREB/Sp1-mediated MCL1 expression and NFκB-mediated ABCB1 expression modulate the cytotoxicity of daunorubicin in chronic myeloid leukemia cells.
Chiou JT; Huang CH; Wu TH; Wang LJ; Lee YC; Huang PW; Chang LS
Toxicol Appl Pharmacol; 2022 Jan; 435():115847. PubMed ID: 34963561
[TBL] [Abstract][Full Text] [Related]
4. AMPK inhibition induces MCL1 mRNA destabilization via the p38 MAPK/miR-22/HuR axis in chronic myeloid leukemia cells.
Lee YC; Chiou JT; Chang LS
Biochem Pharmacol; 2023 Mar; 209():115442. PubMed ID: 36720359
[TBL] [Abstract][Full Text] [Related]
5. BCL2 inhibitor ABT-199 and BCL2L1 inhibitor WEHI-539 coordinately promote NOXA-mediated degradation of MCL1 in human leukemia cells.
Chiou JT; Lee YC; Wang LJ; Chang LS
Chem Biol Interact; 2022 Jul; 361():109978. PubMed ID: 35561756
[TBL] [Abstract][Full Text] [Related]
6. Autophagic HuR mRNA degradation induces survivin and MCL1 downregulation in YM155-treated human leukemia cells.
Chiou JT; Lee YC; Huang CH; Shi YJ; Wang LJ; Chang LS
Toxicol Appl Pharmacol; 2020 Jan; 387():114857. PubMed ID: 31837377
[TBL] [Abstract][Full Text] [Related]
7. ONC212 enhances YM155 cytotoxicity by triggering SLC35F2 expression and NOXA-dependent MCL1 degradation in acute myeloid leukemia cells.
Chiou JT; Chang LS
Biochem Pharmacol; 2024 Jun; 224():116242. PubMed ID: 38679209
[TBL] [Abstract][Full Text] [Related]
8. Hydroquinone-induced miR-122 down-regulation elicits ADAM17 up-regulation, leading to increased soluble TNF-α production in human leukemia cells with expressed Bcr/Abl.
Chen YJ; Chang LS
Biochem Pharmacol; 2013 Sep; 86(5):620-31. PubMed ID: 23791922
[TBL] [Abstract][Full Text] [Related]
9. LncRNA highly upregulated in liver cancer regulates imatinib resistance in chronic myeloid leukemia via the miR-150-5p/MCL1 axis.
Han Y; Ma Z
Anticancer Drugs; 2021 Apr; 32(4):427-436. PubMed ID: 33587348
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Sp1-mediated survivin and MCL1 expression cooperates with SLC35F2 and myeloperoxidase to modulate YM155 cytotoxicity to human leukemia cells.
Chiou JT; Lee YC; Huang CH; Wang LJ; Shi YJ; Chang LS
Biochem Pharmacol; 2021 Jun; 188():114544. PubMed ID: 33831396
[TBL] [Abstract][Full Text] [Related]
11. p38 MAPK/PP2Acα/TTP pathway on the connection of TNF-α and caspases activation on hydroquinone-induced apoptosis.
Liu WH; Chou WM; Chang LS
Carcinogenesis; 2013 Apr; 34(4):818-27. PubMed ID: 23288922
[TBL] [Abstract][Full Text] [Related]
12. Albendazole-Induced SIRT3 Upregulation Protects Human Leukemia K562 Cells from the Cytotoxicity of MCL1 Suppression.
Wang LJ; Liou LR; Shi YJ; Chiou JT; Lee YC; Huang CH; Huang PW; Chang LS
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486166
[TBL] [Abstract][Full Text] [Related]
13. Amsacrine downregulates BCL2L1 expression and triggers apoptosis in human chronic myeloid leukemia cells through the SIDT2/NOX4/ERK/HuR pathway.
Lee YC; Chiou JT; Wang LJ; Chen YJ; Chang LS
Toxicol Appl Pharmacol; 2023 Sep; 474():116625. PubMed ID: 37451322
[TBL] [Abstract][Full Text] [Related]
14. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia.
Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D
Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353
[TBL] [Abstract][Full Text] [Related]
15. Synergistic cytotoxicity of decitabine and YM155 in leukemia cells through upregulation of SLC35F2 and suppression of MCL1 and survivin expression.
Chiou JT; Chang LS
Apoptosis; 2024 Apr; 29(3-4):503-520. PubMed ID: 38066391
[TBL] [Abstract][Full Text] [Related]
16. Asparaginase induces apoptosis and cytoprotective autophagy in chronic myeloid leukemia cells.
Song P; Ye L; Fan J; Li Y; Zeng X; Wang Z; Wang S; Zhang G; Yang P; Cao Z; Ju D
Oncotarget; 2015 Feb; 6(6):3861-73. PubMed ID: 25738356
[TBL] [Abstract][Full Text] [Related]
17. NOXA-mediated degradation of MCL1 and BCL2L1 causes apoptosis of daunorubicin-treated human acute myeloid leukemia cells.
Chiou JT; Huang NC; Huang CH; Wang LJ; Lee YC; Shi YJ; Chang LS
J Cell Physiol; 2021 Nov; 236(11):7356-7375. PubMed ID: 33982799
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of
Deng Y; Li X; Feng J; Zhang X
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29559564
[TBL] [Abstract][Full Text] [Related]
19. Compound C induces autophagy and apoptosis in parental and hydroquinone-selected malignant leukemia cells through the ROS/p38 MAPK/AMPK/TET2/FOXP3 axis.
Chiou JT; Huang CH; Lee YC; Wang LJ; Shi YJ; Chen YJ; Chang LS
Cell Biol Toxicol; 2020 Aug; 36(4):315-331. PubMed ID: 31900833
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of EGFR pathway promotes the cytotoxicity of ABT-263 in human leukemia K562 cells by blocking MCL1 upregulation.
Lee YC; Wang LJ; Huang CH; Chiou JT; Shi YJ; Chang LS
Biochem Pharmacol; 2020 Aug; 178():114047. PubMed ID: 32446890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]